Surrozen, Inc. (SRZN)
NASDAQ·Healthcare·Biotechnology
$30.87
+3.07%
Mkt Cap $227.49M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 23, 2026 | $661.00K | $514.00K | -22.24% | -$1.41 | -$7.59 | -438.30% | — | — |
| Q4 2025 Nov 7, 2025 | — | $983.00K | — | -$1.17 | -$3.61 | -208.55% | — | — |
| Q3 2025 Aug 8, 2025 | — | $983.00K | — | -$1.23 | -$1.14 | +7.32% | — | — |
| Q2 2025 May 9, 2025 | — | $983.00K | — | -$1.09 | -$3.13 | -187.16% | — | — |
| Q1 2025 Mar 31, 2025 | — | $655.00K | — | -$2.54 | -$9.10 | -258.27% | — | — |
| Q4 2024 Nov 6, 2024 | — | $10.00M | — | -$2.77 | -$0.44 | +84.12% | — | — |
| Q3 2024 Aug 12, 2024 | — | — | — | -$2.79 | -$1.54 | +44.80% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$4.25 | -$4.24 | +0.24% | — | — |
| Q1 2024 Mar 27, 2024 | — | $4.15M | — | -$3.00 | -$4.41 | -47.00% | — | — |
| Q4 2023 Nov 8, 2023 | — | — | — | -$4.20 | -$4.35 | -3.57% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$6.00 | -$4.65 | +22.50% | — | — |
| Q2 2023 May 10, 2023 | — | — | — | -$5.10 | -$7.20 | -41.18% | — | — |
| Q1 2023 Mar 22, 2023 | — | $12.50M | — | -$6.75 | -$0.45 | +93.33% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$6.45 | -$5.70 | +11.63% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$6.90 | -$6.00 | +13.04% | — | — |
| Q2 2022 May 11, 2022 | — | — | — | -$8.10 | -$3.45 | +57.41% | — | — |
| Q1 2022 Mar 24, 2022 | — | — | — | -$7.80 | -$5.25 | +32.69% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$0.38 | -$0.51 | -34.21% | — | — |
| Q3 2021 Aug 6, 2021 | — | — | — | — | -$0.36 | — | — | — |
| Q3 2021 Jul 15, 2021 | — | — | — | — | -$0.37 | — | — | — |